Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Calquence data across four trials reinforces cardiovascular safety profile in patients with chronic lymphocytic leukaemia
-
Calquence shows long-term efficacy and tolerability at three years for patients with relapsed or refractory mantle cell lymphoma
-
AstraZeneca demonstrates growing leadership in breast cancer at SABCS with data from its innovative medicines and robust pipeline
-
Crestor to be divested to Grünenthal in Europe
-
Forxiga approved in Japan for chronic heart failure
-
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
-
Imfinzi approved in the US for less-frequent, fixed-dose use
-
AstraZeneca demonstrates strengths in haematology with robust data at ASH 2020
-
Update on CALAVI Phase II trials for Calquence in patients hospitalised with respiratory symptoms of COVID-19
-
Tezepelumab NAVIGATOR Phase III trial met primary endpoint of a statistically significant and clinically meaningful reduction in exacerbations in a broad population of patients with severe asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
